SETD2 and nonpapillary renal cell carcinoma: In ccRCC pathogenesis, ~10–20% of tumors acquire SETD2 mutation on the second intact allele (or more rarely acquire mutations on both alleles) resulting in biallelic loss of SETD2 and H3K36me3 depletion (9, 18, 19).